WO2007007183A3 - Compositions of antiviral compound - Google Patents

Compositions of antiviral compound Download PDF

Info

Publication number
WO2007007183A3
WO2007007183A3 PCT/IB2006/001952 IB2006001952W WO2007007183A3 WO 2007007183 A3 WO2007007183 A3 WO 2007007183A3 IB 2006001952 W IB2006001952 W IB 2006001952W WO 2007007183 A3 WO2007007183 A3 WO 2007007183A3
Authority
WO
WIPO (PCT)
Prior art keywords
ribavirin
compositions
antiviral compound
free flowing
agglomerating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2006/001952
Other languages
French (fr)
Other versions
WO2007007183A2 (en
Inventor
Amod Vishvanath Dhabu
Mohinder Paul Pakhetra
Ashish Gogia
Sivakumaran Meenakshisunderam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aurobindo Pharma Ltd
Original Assignee
Aurobindo Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurobindo Pharma Ltd filed Critical Aurobindo Pharma Ltd
Priority to EP06765637A priority Critical patent/EP1904071A2/en
Publication of WO2007007183A2 publication Critical patent/WO2007007183A2/en
Publication of WO2007007183A3 publication Critical patent/WO2007007183A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

An oral pharmaceutical composition comprising free flowing ribavirin and one or more pharmaceutically acceptable excipients, wherein the free flowing ribavirin is prepared by agglomerating the non-free flowing ribavirin using a solvent or by controlling the crystallization during synthesis of ribavirin.
PCT/IB2006/001952 2005-07-08 2006-07-05 Compositions of antiviral compound Ceased WO2007007183A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06765637A EP1904071A2 (en) 2005-07-08 2006-07-05 Compositions of antiviral compound

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN906/CHE/2005 2005-07-08
IN906CH2005 2005-07-08

Publications (2)

Publication Number Publication Date
WO2007007183A2 WO2007007183A2 (en) 2007-01-18
WO2007007183A3 true WO2007007183A3 (en) 2007-08-23

Family

ID=37564409

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/001952 Ceased WO2007007183A2 (en) 2005-07-08 2006-07-05 Compositions of antiviral compound

Country Status (2)

Country Link
EP (1) EP1904071A2 (en)
WO (1) WO2007007183A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1281715A1 (en) * 2001-07-30 2003-02-05 Clariant Life Science Molecules (Italia) SpA Process for the preparation of ribavirin
US20040258751A1 (en) * 2002-09-19 2004-12-23 Kerrish Donald J. Composition containing ribavirin and use thereof
EP1455801B1 (en) * 2001-12-21 2005-03-09 Biopartners GmbH Ribavirin granulate for producing coated tablets

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1281715A1 (en) * 2001-07-30 2003-02-05 Clariant Life Science Molecules (Italia) SpA Process for the preparation of ribavirin
EP1455801B1 (en) * 2001-12-21 2005-03-09 Biopartners GmbH Ribavirin granulate for producing coated tablets
US20040258751A1 (en) * 2002-09-19 2004-12-23 Kerrish Donald J. Composition containing ribavirin and use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TONG H H Y ET AL: "An improved thermoanalytical approach to quantifying trace levels of polymorphic impurity in drug powders", INTERNATIONAL JOURNAL OF PHARMACEUTICS, AMSTERDAM, NL, vol. 295, no. 1-2, 13 May 2005 (2005-05-13), pages 191 - 199, XP004852854, ISSN: 0378-5173 *

Also Published As

Publication number Publication date
EP1904071A2 (en) 2008-04-02
WO2007007183A2 (en) 2007-01-18

Similar Documents

Publication Publication Date Title
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
MY155402A (en) Pharmaceutical composition of a potent hcv inhibitor for oral administration
WO2007135527A3 (en) Benzimidazolyl compounds
WO2004085385A3 (en) Cannabinoid receptor ligands
WO2008049116A3 (en) Substituted indoles
WO2007099548A3 (en) Novel 11 beta - hydroxyandrosta-4-ene-3-ones
AU2003246810A1 (en) Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
WO2007096151A3 (en) Inhibitors of p38-kinase for treatment of pulmonary hypertension
WO2006046030A3 (en) Tetracyclic indole derivatives as antiviral agents
TW200744588A (en) Pharmaceutical composition for external use
WO2008092954A3 (en) Polymorphic forms of a macrocyclic inhibitor of hcv
WO2007107470A3 (en) Pyrazoles as 11-beta-hsd-1
WO2007090882A3 (en) Pharmaceutical extended release compositions comprising pramipexole
WO2009051119A1 (en) Pyrimidyl indoline compound
WO2008072053A3 (en) Substituted arylpyrazoles
WO2007146856A3 (en) Substituted gamma lactams as therapeutic agents
WO2008008718A3 (en) Cyclopentane derivatives as antiglaucoma agents
WO2007014054A3 (en) Benzenesulfonamide inhibitor of ccr2 chemokine receptor
WO2005115470A3 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING β-CARBOLINE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF CANCER
WO2008008660A3 (en) Cyclopentane derivatives as antiglaucoma agents
WO2008008700A3 (en) Substituted cyclopentane derivatives as therapeutic agents
WO2008021975A3 (en) Therapeutic lactams
WO2006042954A8 (en) 2-amido-4-phenylthiazole derivatives, the preparation and the therapeutic use thereof
WO2008021804A3 (en) Therapeutic amides and related compounds
WO2008093838A1 (en) Pyridyl imidazolidine derivative having sulfamoyl group, and pharmaceutical use thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2006765637

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06765637

Country of ref document: EP

Kind code of ref document: A2

WWP Wipo information: published in national office

Ref document number: 2006765637

Country of ref document: EP